Vinayak Pharma Chem Pvt.Ltd.
Chemical manufacturing and distribution company established in 1995.
1995 | Kolkata, West Bengal (India) | Active
Vinayak Pharma Chem.Ltd. Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.43 M
- Company Age 29 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 7.53%
- Profit Growth 91.71%
- Ebitda 7.36%
- Net Worth 1.54%
- Total Assets 1.52%
About Vinayak Pharma Chem.Ltd.
Vinayak Pharma Chem Pvt.Ltd. (VPCP) is a Private Limited Indian Non-Government Company incorporated in India on 02 June 1995 and has a history of 29 years and eight months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.43 M, as per Ministry of Corporate Affairs (MCA) records.
Santosh Lakhotia and Mahesh Lakhotia serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U29197WB1995PTC071935
- Company No.
071935
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jun 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Pharma
Chemicals and Materials
Who are the key members and board of directors at Vinayak Pharma Chem.Ltd.?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Lakhotia  | Director | 05-May-2001 | Current |
| Mahesh Lakhotia | Director | 02-Jun-1995 | Current |
Financial Performance of Vinayak Pharma Chem.Ltd..
Vinayak Pharma Chem Pvt.Ltd., for the financial year ended 2020, experienced modest growth in revenue, with a 7.53% increase. The company also saw a substantial improvement in profitability, with a 91.71% increase in profit. The company's net worth moved up by a moderate rise of 1.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vinayak Pharma Chem.Ltd.?
In 2020, Vinayak Pharma Chem.Ltd. had a promoter holding of 41.49% and a public holding of 58.51%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vinayak Pharma Chem.Ltd.?
Unlock and access historical data on people associated with Vinayak Pharma Chem.Ltd., such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vinayak Pharma Chem.Ltd., offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vinayak Pharma Chem.Ltd.'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.